Clearside Biomedical
is a Georgia-based pharmaceutical company that researches, develops, and commercializes pharmacological therapies for the treatment of eye diseases... Read moreClearside Biomedical
is a Georgia-based pharmaceutical company that researches, develops, and commercializes pharmacological therapies for the treatment of eye diseases... Read more
News
Nov 26, 2025
ABF Journal
Clearside Biomedical: Clearside Biomedical to Pursue Strategic Sale Through Voluntary Chapter 11 Process
Aug 26, 2025
Benzinga
Clearside Biomedical: Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
Jul 23, 2025
RTTNews
Clearside Biomedical: Why Clearside Biomedical Is Rising In Pre-market?
Jun 17, 2025
Benzinga
Clearside Biomedical: Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
May 21, 2025
Benzinga
Clearside Biomedical: Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
May 16, 2025
Owler
Clearside Biomedical, Inc.: Clearside Biomedical's revenue changed from $1.66M in Dec 2024 to $3.76M in Mar 2025
May 15, 2025
VisionMonday
Clearside Biomedical: Clearside Biomedical Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
Yahoo
Clearside Biomedical: Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates
May 09, 2025
Benzinga
Clearside Biomedical: Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Mar 28, 2025
Seeking Alpha
Clearside Biomedical: Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call Transcript
Clearside Biomedical Competitors
1
2
3
4
5
6
7
8
9
10